Boothbay Fund Management LLC raised its stake in American Healthcare REIT, Inc. (NYSE:AHR – Free Report) by 29.3% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 308,575 shares of the company’s stock after buying an additional 69,925 shares during the period. Boothbay Fund Management LLC’s holdings in American Healthcare REIT were worth $11,337,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Creative Planning increased its holdings in American Healthcare REIT by 4.5% during the 2nd quarter. Creative Planning now owns 37,467 shares of the company’s stock worth $1,377,000 after purchasing an additional 1,628 shares during the period. Envestnet Portfolio Solutions Inc. bought a new position in shares of American Healthcare REIT during the 2nd quarter worth $207,000. Franklin Resources Inc. increased its stake in shares of American Healthcare REIT by 44.3% during the second quarter. Franklin Resources Inc. now owns 236,110 shares of the company’s stock valued at $8,675,000 after buying an additional 72,502 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of American Healthcare REIT by 4.2% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,235,051 shares of the company’s stock valued at $67,722,000 after acquiring an additional 89,926 shares in the last quarter. Finally, Beacon Financial Advisory LLC bought a new stake in shares of American Healthcare REIT in the second quarter valued at about $230,000. 16.68% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research analysts have commented on AHR shares. UBS Group raised their target price on shares of American Healthcare REIT from $51.00 to $56.00 and gave the company a “buy” rating in a research report on Monday, November 17th. Citizens Jmp boosted their price objective on shares of American Healthcare REIT from $50.00 to $60.00 and gave the stock a “market outperform” rating in a research note on Monday, November 10th. Truist Financial upped their target price on American Healthcare REIT from $46.00 to $53.00 and gave the stock a “buy” rating in a report on Wednesday, November 26th. KeyCorp lifted their price target on American Healthcare REIT from $43.00 to $55.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Finally, Citigroup boosted their price target on American Healthcare REIT from $45.00 to $52.00 and gave the stock a “neutral” rating in a research report on Friday, November 21st. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $51.64.
American Healthcare REIT Stock Performance
Shares of AHR opened at $47.24 on Friday. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.37. The firm has a market cap of $8.36 billion, a PE ratio of 337.44, a P/E/G ratio of 1.95 and a beta of 0.93. American Healthcare REIT, Inc. has a 12 month low of $26.40 and a 12 month high of $51.01. The stock has a fifty day moving average price of $46.39 and a 200-day moving average price of $41.55.
American Healthcare REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, October 17th. Shareholders of record on Tuesday, September 30th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Tuesday, September 30th. American Healthcare REIT’s dividend payout ratio (DPR) is currently 714.29%.
Insider Transactions at American Healthcare REIT
In other news, EVP Mark E. Foster sold 1,500 shares of the company’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $49.35, for a total transaction of $74,025.00. Following the transaction, the executive vice president owned 57,600 shares in the company, valued at $2,842,560. This represents a 2.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Jeffrey T. Hanson sold 20,010 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $49.68, for a total transaction of $994,096.80. Following the completion of the transaction, the director directly owned 21,798 shares of the company’s stock, valued at $1,082,924.64. The trade was a 47.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.92% of the stock is currently owned by insiders.
About American Healthcare REIT
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
See Also
- Five stocks we like better than American Healthcare REIT
- Investing in the High PE Growth Stocks
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- Investing in Travel Stocks Benefits
- The Best Holiday Present You Can Give Yourself? Costco Stock
- Growth Stocks: What They Are, Examples and How to Invest
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR – Free Report).
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
